Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rhodamine 110 (Fluorescence Reference Standard) from AnaSpec
Mouse Anti-Human PPOX Monoclonal Antibody, Unconjugated, Clone 2F10 from ABR-Affinity BioReagents
Biology Products:...bite is horrible. The immediate pain of the bite i...n sweating or chills, with numbness, nausea, blurr... over. Such misery is produced by a veritable witc...een thought that the body,s own immune system, rat...rse. But now researchers at the Stanford Universit...
...in can turn on and off a key component of the immu...ic dance, said researchers at the University of So...ecause autoimmune diseases ?such as arthritis, all...he body,s defenses respond at the wrong time or pl...s been the subject of intense study for decades. ...
...sociated with early Alzheimer,s disease (AD) may b...he brain, according to a study in the July issue o...Duke University Medical Center in Durham, N.C., us...netic resonance imaging (fMRI) scanner to study th...itive impairment (MCI), a precursor to AD, and fou...
Other Biology News:Stanford snake venom study shows that certain cells may eliminate poison 2Stanford snake venom study shows that certain cells may eliminate poison 3Stanford snake venom study shows that certain cells may eliminate poison 4Flick of a protein switches immune response 2Memory loss affects more of the brain than previously thought 2(Date:11/24/2009)... MATEO, Calif., Nov. 24 ...cal company focused on developing and commercializ...ay that Anthony DiTonno, President and Chief Execu...Annual Piper Jaffray Health Care Conference, to be...tel in New York, New York. ,, Mr. DiTonno and ...
(Date:11/24/2009)....24/PRNewswire/--BlueMarbleEnergyCorp.announcedtod...rity(OPDA)wererecentlyawarded$2millionbyWashington...naprivate/publicpartnershiptoconstructthestate,sfi...WA. ,, "Thisinvestmentwillsignificantlyspeedthe...toLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilv...
(Date:11/24/2009)...rimary efficacy endpoint has been met for patients...cancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fi...TSX: AEZ) (the "Company"), a global biopharmaceuti...ogy, today announced positive efficacy data from a... conjugate, AEZS-108 (formerly AN-152), in patient...
(Date:11/24/2009)...BLIN, November 24 Shire ...lty biopharmaceutical company, today,announced tha... Agency for,velaglucerase alfa, the company,s enzy...tment of Type 1 Gaucher disease. This is the third... has been submitted, with previous,submissions in ...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4